September 02, 2021 article Open access Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network Dermatology DOI: 10.1159/000517830 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 2 stored of 12 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023 2023 European Journal of Cancer article Medicine Cutaneous lymphoproliferative disorders research Open access 189 citations Kutane T-Zell-Lymphome: Low-dose Gemcitabin in der Therapie fortgeschrittener CTCL 2022 Kompass Dermatologie article Medicine Cutaneous lymphoproliferative disorders research 0 citations 2 results References 0